Takeo Yoshikawa
Affiliations: | Laboratory for Molecular Psychiatry | RIKEN Center for Brain Science |
Google:
"Takeo Yoshikawa"Mean distance: (not calculated yet)
Children
Sign in to add traineeMotoko Maekawa | research scientist | RIKEN Center for Brain Science | |
Tetsuo Ohnishi | research scientist | RIKEN Center for Brain Science | |
Shabeesh Balan | research scientist | 2012-2021 | RIKEN Center for Brain Science |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Kushima I, Nakatochi M, Aleksic B, et al. (2022) Cross-Disorder Analysis of Genic and Regulatory Copy Number Variations in Bipolar Disorder, Schizophrenia, and Autism Spectrum Disorder. Biological Psychiatry |
Uezato A, Jitoku D, Shimazu D, et al. (2022) Differential genetic associations and expression of PAPST1/SLC35B2 in bipolar disorder and schizophrenia. Journal of Neural Transmission (Vienna, Austria : 1996) |
Balan S, Iwayama Y, Ohnishi T, et al. (2021) A loss-of-function variant in SUV39H2 identified in autism-spectrum disorder causes altered H3K9 trimethylation and dysregulation of protocadherin β-cluster genes in the developing brain. Molecular Psychiatry |
Hara T, Toyoshima M, Hisano Y, et al. (2021) Glyoxalase I disruption and external carbonyl stress impair mitochondrial function in human induced pluripotent stem cells and derived neurons. Translational Psychiatry. 11: 275 |
Ohnishi T, Kiyama Y, Arima-Yoshida F, et al. (2021) Cooperation of LIM domain-binding 2 (LDB2) with EGR in the pathogenesis of schizophrenia. Embo Molecular Medicine. e12574 |
Balan S, Ohnishi T, Watanabe A, et al. (2021) Role of an Atypical Cadherin Gene, Cdh23 in Prepulse Inhibition, and Implication of CDH23 in Schizophrenia. Schizophrenia Bulletin |
Ogata S, Hashizume K, Hayase Y, et al. (2021) Potential involvement of DSCAML1 mutations in neurodevelopmental disorders. Genes to Cells : Devoted to Molecular & Cellular Mechanisms |
Oishi K, Niitsu T, Kanahara N, et al. (2021) Genetic risks of schizophrenia identified in a matched case-control study. European Archives of Psychiatry and Clinical Neuroscience. 271: 775-781 |
Wada Y, Maekawa M, Ohnishi T, et al. (2020) Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia. Ebiomedicine. 103130 |
Hayase Y, Amano S, Hashizume K, et al. (2020) Down syndrome cell adhesion molecule like-1 (DSCAML1) links the GABA system and seizure susceptibility. Acta Neuropathologica Communications. 8: 206 |